FibroGen Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
122,809.00
179,819.00
181,171.00
253,179.00
735,718.00
621,402
Total Accounts Receivable
17,495.00
13,453.00
15,405.00
10,448.00
8,452.00
63,684
Other Current Assets
3,339.00
4,966.00
3,988.00
2,889.00
4,800.00
4,929
Total Current Assets
143,643.00
198,238.00
200,564.00
266,516.00
748,970.00
690,015
Net Property, Plant & Equipment
129,898.00
132,171.00
129,020.00
123,657.00
129,476.00
127,198
Total Investments and Advances
22,610.00
151,523.00
138,974.00
77,227.00
15,687.00
59,965
Other Assets
801.00
1,596.00
2,016.00
2,152.00
4,517.00
3,420
Total Assets
296,952.00
483,528.00
470,574.00
469,552.00
898,650.00
880,598
ST Debt & Current Portion LT Debt
403.00
403.00
-
-
-
Accounts Payable
1,066.00
4,851.00
6,521.00
6,223.00
5,509.00
Other Current Liabilities
36,010.00
57,500.00
60,660.00
58,902.00
71,749.00
Total Current Liabilities
37,479.00
62,754.00
67,181.00
65,125.00
77,258.00
Long-Term Debt
96,406.00
108,283.00
107,327.00
107,306.00
109,107.00
Other Liabilities
55,464.00
71,815.00
99,241.00
122,012.00
129,835.00
Total Liabilities
189,349.00
242,852.00
273,749.00
294,443.00
316,200.00
Common Equity (Total)
225,021.00
221,405.00
177,554.00
155,838.00
563,179.00
Total Shareholders' Equity
79,728.00
221,405.00
177,554.00
155,838.00
563,179.00
Total Equity
107,603.00
240,676.00
196,825.00
175,109.00
582,450.00
Liabilities & Shareholders' Equity
296,952.00
483,528.00
470,574.00
469,552.00
898,650.00
Accumulated Minority Interest
27,875.00
19,271.00
19,271.00
19,271.00
19,271.00
Preferred Stock (Carrying Value)
304,749.00
-
-
-
-

About FibroGen

View Profile
Address
409 Illinois Street
San Francisco California 94158
United States
Employees -
Website http://www.fibrogen.com
Updated 07/08/2019
FibroGen, Inc. engages in the discovery, development, and commercialization of therapeutics to treat unmet medical needs. It focuses on fibrosis and hypoxia-induced factor biology to generate programs targeting therapeutic areas. The company was founded by Thomas B.